Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of molecular medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00109-005-0718-5PMID 16283142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial infarction increases ACE2 expression in rat and humans.

  2005cited by this paper
• Context-dependency of the relation between left ventricular mass and AGT gene variants

  2004cited by this paper
• ACE2 gene expression is up-regulated in the human failing heart

  2004cited by this paper
• Left Ventricular Mass in Relation to Genetic Variation in Angiotensin II Receptors, Renin System Genes, and Sodium Excretion

  2004cited by this paper
• No association of Angiotensin-Converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension

  2004cited by this paper
• A story of two ACEs

  2003cited by this paper
• Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent Arterioles

  2002cited by this paper
• Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.

  2002cited by this paper
• Score tests for association between traits and haplotypes when linkage phase is ambiguous.

  2002cited by this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002influential reference
• Just the beginning: novel functions for angiotensin-converting enzymes.

  2002cited by this paper
• Angiotensin‐(1‐7) is involved in the endothelium‐dependent modulation of phenylephrine‐induced contraction in the aorta of mRen‐2 transgenic rats

  2002cited by this paper
• Renin angiotensin system and gender differences in the cardiovascular system.

  2002influential reference
• Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

  2002cited by this paper
• Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans.

  2001cited by this paper
• Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PR

  2001cited by this paper
• Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension.

  2001cited by this paper
• A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

  2000cited by this paper
• A Human Homolog of Angiotensin-converting Enzyme

  2000cited by this paper
• Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension.

  2000cited by this paper
• Body composition and prevalence of left ventricular hypertrophy.

  2000cited by this paper
• Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure.

  1999cited by this paper
• Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

  1998cited by this paper
• Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study.

  1998cited by this paper
• Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males.

  1998cited by this paper
• Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

  1997cited by this paper
• Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats.

  1995cited by this paper
• Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II.

  1995cited by this paper
• Angiotensin‐Converting Enzyme Inhibition Prolongs Survival and Modifies the Transition to Heart Failure in Rats With Pressure Overload Hypertrophy Due to Ascending Aortic Stenosis

  1994cited by this paper
• Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

  1994cited by this paper
• DD Genotype of the Angiotensin‐Converting Enzyme Gene Is a Risk Factor for Left Ventricular Hypertrophy

  1994cited by this paper
• Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

  1990influential reference
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986influential reference
• Standardization of M-mode echocardiographic left ventricular anatomic measurements.

  1984cited by this paper
• Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

  1976cited by this paper

• Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions

  2025cites this paper
• Machine learning approaches and genetic determinants that influence the development of type 2 diabetes mellitus: a genetic association study in Brazilian patients

  2024cites this paper
• Effects of sacubitril-valsartan on aging-related cardiac dysfunction.

  2024cites this paper
• Hydroxychloroquine in SARS-CoV-2 infection: Understanding the misadventure

  2024cites this paper
• The RAAS Goodfellas in Cardiovascular System

  2023cites this paper
• Correlation between angiotensin-converting-enzyme 2 gene polymorphisms and systemic sclerosis.

  2023cites this paper
• Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities

  2023cites this paper
• An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect.

  2022cites this paper
• Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?

  2022cites this paper
• Association of ACE2 Gene Variants with the Severity of COVID-19 Disease—A Prospective Observational Study

  2022cites this paper
• Ethnicity-based classifications and medical genetics: One Health approaches from a Western Pacific perspective

  2022cites this paper
• Associations between the TNMD rs4828038 and ACE2 rs879922 polymorphisms and preeclampsia susceptibility: a case-control study

  2022cites this paper
• Lineage-specific positive selection on ACE2 contributes to the genetic susceptibility of COVID-19

  2022cites this paper
• Association of ACE2 Polymorphisms and Derived Haplotypes With Obesity and Hyperlipidemia in Female Spanish Adolescents

  2021cites this paper
• The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population

  2021cites this paper
• Association of ACE2 variant rs4646188 with the risks of atrial fibrillation and cardioembolic stroke in Uygur patients with type 2 diabetes

  2021cites this paper
• Aging versus youth: Endocrine aspects of vulnerability for COVID-19

  2021cites this paper
• Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants

  2021cites this paper
• Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

  2021cites this paper
• Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection

  2021cites this paper
• Exploring AT2R and its polymorphism in different diseases: An approach to develop AT2R as a drug target beyond hypertension.

  2021cites this paper
• ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review

  2021cites this paper
• The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy

  2021cites this paper
• The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients

  2020cites this paper
• ACE2: the molecular doorway to SARS-CoV-2

  2020cites this paper
• Allele Frequency of ACE2 Intron Variants and Its Association with Blood Pressure

  2020cites this paper
• The Perfect Storm: COVID-19 Health Disparities in US Blacks

  2020cites this paper
• COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients

  2020cites this paper
• Covid-19 infection and the host genetic predisposition: does it exist?

  2020cites this paper
• The Age Pattern of the Male- to- Female Ratio in Mortality from COVID-19 Mirrors that of Cardiovascular Disease but not Cancer in the General Population

  2020cites this paper
• SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

  2020cites this paper
• The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19

  2020cites this paper
• Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease

  2019cites this paper
• Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang

  2018cites this paper
• The Association Between ACE2 Gene Polymorphism and the Stroke Recurrence in Chinese Population.

  2018cites this paper
• ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus

  2018cites this paper
• Fetal But Not Maternal Angiotensin Converting Enzyme (ACE)-2 Gene Rs2074192 Polymorphism is Associated with Increased Risk of Being a Small For Gestational Age (SGA) Newborn

  2018cites this paper
• Future drug discovery in renin-angiotensin-aldosterone system intervention

  2017cites this paper
• Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus

  2017cites this paper
• FGF23 from bench to bedside.

  2016cites this paper
• FGF 23 from bench to bedside

  2016cites this paper
• Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

  2016cites this paper
• DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis

  2016cites this paper
• Association between circulating levels of ACE2-Ang-(1–7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients

  2016cites this paper
• ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy

  2015cites this paper
• Early life perfluorooctanesulphonic acid (PFOS) exposure impairs zebrafish organogenesis.

  2014cites this paper
• ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury

  2014cites this paper
• From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension

  2014influential citation
• Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

  2014cites this paper
• Polymorphisms of angiotensin‐converting enzyme 2 gene confer a risk to lone atrial fibrillation in Chinese male patients

  2013cites this paper
• The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents

  2013cites this paper
• ACE2 gene polymorphisms and invasively measured central pulse pressure in cardiac patients indicated for coronarography

  2013cites this paper
• The ACE2 gene: its potential as a functional candidate for cardiovascular disease.

  2013cites this paper
• The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease.

  2013cites this paper
• Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases.

  2013cites this paper
• Angiotensin‐converting enzyme 2 polymorphisms and cardiovascular risk

  2012cites this paper
• Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes.

  2012cites this paper
• Polymorphisms of ACE2 are associated with blood pressure response to cold pressor test: the GenSalt study.

  2012cites this paper
• Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure

  2012cites this paper
• Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy

  2012cites this paper
• Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system

  2012cites this paper
• Role of ACE2 in diastolic and systolic heart failure

  2012cites this paper
• Four Genetic Loci Influencing Electrocardiographic Indices of Left Ventricular Hypertrophy

  2011cites this paper
• Recombinant Human Angiotensin-Converting Enzyme 2 as a New Renin-Angiotensin System Peptidase for Heart Failure Therapy

  2011cites this paper
• Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23.

  2011cites this paper
• Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition

  2011cites this paper
• A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project

  2011cites this paper
• Role of Modifier Genes in Idiopathic Cardiomyopathies

  2011cites this paper
• Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10 p 11 . 23

  2010cites this paper
• Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study.

  2010cites this paper
• Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

  2010cites this paper
• Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters

  2010cites this paper
• Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all

  2010cites this paper
• Familial hypertrophic cardiomyopathy: basic concepts and future molecular diagnostics.

  2009cites this paper
• Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

  2009cites this paper
• Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension.

  2009cites this paper
• The role of renin-angiotensin-aldosterone system (RAAS) genes in the development of hypertrophy in hypertrophic cardiomyopathy (HCM)

  2009influential citation
• Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

  2009cites this paper
• The Association of African Ancestry and Elevated Creatinine in the Coronary Artery Risk Development in Young Adults (CARDIA) Study

  2009cites this paper
• Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction

  2009cites this paper
• Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.

  2008cites this paper
• New aspects of the renin–angiotensin system: angiotensin-converting enzyme 2 – a potential target for treatment of hypertension and diabetic nephropathy

  2008cites this paper
• Lack of Association Between the MEF2A Gene and Myocardial Infarction

  2008cites this paper
• Lack of association of genetic variants in the LRP8 gene with familial and sporadic myocardial infarction

  2008cites this paper
• Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.

  2008cites this paper
• Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans.

  2008cites this paper
• Association between PPARalpha gene polymorphisms and myocardial infarction.

  2008cites this paper
• Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors.

  2008cites this paper
• Angiotensin‐converting enzyme 2 in the brain: properties and future directions

  2008cites this paper
• The renin–angiotensin system and diabetes: An update

  2008cites this paper
• Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function

  2008cites this paper
• Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort.

  2008cites this paper
• Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axis

  2008cites this paper
• Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy

  2008influential citation
• Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.

  2008cites this paper
• Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease

  2008cites this paper
• ACE2 of the heart: From angiotensin I to angiotensin (1-7).

  2007cites this paper
• Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese.

  2007cites this paper
• Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.

  2007cites this paper
• Polymorphisms of ACE2 Gene are Associated With Essential Hypertension and Antihypertensive Effects of Captopril in Women

  2007influential citation